ATE432469T1 - Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs - Google Patents

Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs

Info

Publication number
ATE432469T1
ATE432469T1 AT05799643T AT05799643T ATE432469T1 AT E432469 T1 ATE432469 T1 AT E432469T1 AT 05799643 T AT05799643 T AT 05799643T AT 05799643 T AT05799643 T AT 05799643T AT E432469 T1 ATE432469 T1 AT E432469T1
Authority
AT
Austria
Prior art keywords
boris
process based
immune reaction
detecting cancer
reaction against
Prior art date
Application number
AT05799643T
Other languages
English (en)
Inventor
Victor Lobanenkov
Dmitri LOUKINOV
Ziedulla Abdullaev
Svetlana Pack
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE432469T1 publication Critical patent/ATE432469T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05799643T 2004-09-21 2005-09-21 Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs ATE432469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61179804P 2004-09-21 2004-09-21
PCT/US2005/033796 WO2006034335A2 (en) 2004-09-21 2005-09-21 Method of detecting cancer based on immune reaction to boris

Publications (1)

Publication Number Publication Date
ATE432469T1 true ATE432469T1 (de) 2009-06-15

Family

ID=36090647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05799643T ATE432469T1 (de) 2004-09-21 2005-09-21 Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs

Country Status (6)

Country Link
US (1) US7785814B2 (de)
EP (1) EP1802972B1 (de)
AT (1) ATE432469T1 (de)
DE (1) DE602005014659D1 (de)
ES (1) ES2325866T3 (de)
WO (1) WO2006034335A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006082414A1 (en) * 2005-02-03 2006-08-10 Cancer Research Technology Limited Detection and diagnosis of cancer
JP2010502192A (ja) * 2006-08-31 2010-01-28 アメリカ合衆国 Ｂｏｒｉｓアイソフォーム並びに疾患を検出及び治療する方法
US10415094B2 (en) 2016-10-06 2019-09-17 HelicalHelp LLC Risk stratification method for a patient having a polymorphism
EP3914296A4 (de) * 2019-01-25 2022-11-30 Mayo Foundation for Medical Education and Research Bewertung und behandlung von keimzelltumoren und paranoplastischer autoimmunität

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
CA2129663C (en) * 1992-02-06 2005-07-05 James S. Huston Biosynthetic binding protein for cancer marker
EP1573035B1 (de) * 2002-02-22 2015-09-02 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Bruder des regulators geprägter stellen (boris)
US20040152877A1 (en) * 2002-03-14 2004-08-05 Hillman Jennifer L. Nucleic acid-associated proteins
ATE475430T1 (de) * 2003-08-25 2010-08-15 Univax Llc Präventive krebsvakzine auf basis des boris (brother of regulator of imprinted sites) moleküls

Also Published As

Publication number Publication date
US20080095805A1 (en) 2008-04-24
EP1802972B1 (de) 2009-05-27
ES2325866T3 (es) 2009-09-22
US7785814B2 (en) 2010-08-31
DE602005014659D1 (de) 2009-07-09
WO2006034335A2 (en) 2006-03-30
EP1802972A2 (de) 2007-07-04
WO2006034335A3 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
ATE549624T1 (de) Verfahren und zusammensetzungen zur diagnose und behandlung von grippe
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
ATE408828T1 (de) Verfahren zur erkennung eines ovarialkarzinoms
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
WO2009007846A3 (en) Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
MY145455A (en) Diagnostic biomolecule(s)
ATE432469T1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
CY1117709T1 (el) Αναλυτικη μεθοδος για μορια fab και fab'
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
WO2010000467A8 (en) Asc as a marker for lung cancer
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
WO2007095378A3 (en) Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties